ALKEM LABORATORIES
Back to Cashflow Statement
|
ALKEM LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-503 Cr | ₹-811 Cr | ₹-1,145 Cr | ₹-1,761 Cr | ₹380 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALKEM LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-503 Cr |
| Mar2025 | ₹-811 Cr |
| Mar2024 | ₹-1,145 Cr |
| Mar2023 | ₹-1,761 Cr |
| Mar2022 | ₹380 Cr |
How is Cash Flow from Financing Activities of ALKEM LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-503 Cr | Negative | |
| Mar2025 | ₹-811 Cr | Negative | |
| Mar2024 | ₹-1,145 Cr | Negative | |
| Mar2023 | ₹-1,761 Cr | Negative | |
| Mar2022 | ₹380 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹64,942.8 Cr | 4.1% | 2.6% | -6.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹454,914.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹300,380.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,169.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,933.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹114,478.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 4.1% |
2.6% |
-6.4% |
| SENSEX | 5.9% |
13% |
-1.9% |
You may also like the below Video Courses